We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.43B
AUM Growth
+$75.3M
Cap. Flow
-$42M
Cap. Flow %
-1.22%
Top 10 Hldgs %
13.83%
Holding
1,352
New
131
Increased
487
Reduced
534
Closed
83

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$9.73M
2
MSFT icon
Microsoft
MSFT
+$6.54M
3
LMT icon
Lockheed Martin
LMT
+$5.54M
4
DD icon
DuPont de Nemours
DD
+$5.19M
5
AAPL icon
Apple
AAPL
+$4.57M

Sector Composition

Rank Sector Weight
1 Healthcare 14.45%
2 Technology 10.24%
3 Financials 10.23%
4 Industrials 9%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEV icon
1026
iShares Europe ETF
IEV
$1.63B
$275K 0.01%
+6,986
New +$271K
PHYS icon
1027
Sprott Physical Gold
PHYS
$14.6B
$274K 0.01%
+25,049
New +$277K
MQY icon
1028
BlackRock MuniYield Quality Fund
MQY
$807M
$272K 0.01%
16,447
-325
-2% -$5.45K
PBF icon
1029
PBF Energy
PBF
$7.29B
$272K 0.01%
12,000
+3,500
+41% +$78.6K
EWW icon
1030
iShares MSCI Mexico ETF
EWW
$1.89B
$271K 0.01%
5,600
+1,500
+37% +$75.4K
BHI
1031
DELISTED
Baker Hughes
BHI
$271K 0.01%
+5,366
New +$258K
HAIN icon
1032
Hain Celestial
HAIN
$47.8M
$270K 0.01%
7,600
+2,950
+63% +$129K
NICE icon
1033
Nice
NICE
$5.29B
$270K 0.01%
4,024
-250
-6% -$16.6K
BSX icon
1034
Boston Scientific
BSX
$65.8B
$269K 0.01%
11,265
+423
+4% +$10.1K
IYM icon
1035
iShares US Basic Materials ETF
IYM
$1.16B
$268K 0.01%
3,389
+580
+21% +$46K
BHK icon
1036
BlackRock Core Bond Trust
BHK
$642M
$266K 0.01%
18,745
-4,915
-21% -$69.4K
DG icon
1037
Dollar General
DG
$25.9B
$265K 0.01%
+3,786
New +$321K
BIG
1038
DELISTED
Big Lots, Inc.
BIG
$264K 0.01%
+5,521
New +$283K
NAV
1039
DELISTED
Navistar International
NAV
$262K 0.01%
11,456
-43,624
-79% -$664K
MLI icon
1040
Mueller Industries
MLI
$14.1B
$260K 0.01%
32,000
NVG icon
1041
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.65B
$259K 0.01%
16,115
-2,233
-12% -$36.2K
MTRX icon
1042
Matrix Service
MTRX
$347M
$258K 0.01%
13,750
CHH icon
1043
Choice Hotels
CHH
$5.03B
$256K 0.01%
5,688
CSQ icon
1044
Calamos Strategic Total Return Fund
CSQ
$3.21B
$256K 0.01%
24,855
-21,761
-47% -$226K
CLLS
1045
Cellectis
CLLS
$286M
$255K 0.01%
10,604
-1,497
-12% -$39.1K
HIG icon
1046
Hartford Financial Services
HIG
$38.5B
$255K 0.01%
5,954
-3,088
-34% -$129K
HYLS icon
1047
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
$255K 0.01%
5,250
-500
-9% -$24.3K
EXG icon
1048
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.91B
$254K 0.01%
29,230
+1,215
+4% +$10.7K
ACH
1049
Accendra Health
ACH
$240M
$254K 0.01%
7,333
+870
+13% +$30.5K
TREX icon
1050
Trex
TREX
$4.51B
$253K 0.01%
+17,212
New +$240K

Similar funds

Oppenheimer & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Oppenheimer & Co held 1,352 positions worth $3.43B, up 2.2% from $3.35B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2016 filing shows 131 new, 487 increased, 534 reduced and 83 closed positions. Its largest new stake was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M. The largest sale was GE Aerospace, an estimated $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Oppenheimer & Co's largest Q3 2016 buy was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M.
  • Oppenheimer & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $6.72M increase.
  • Oppenheimer & Co's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $9.73M.
  • Oppenheimer & Co fully exited Agrium in Q3 2016, selling an estimated $3.32M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.43B portfolio in Q3 2016.
  • Oppenheimer & Co opened 131 new positions and closed 83 in Q3 2016.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $3.43B.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.